Trevena’s opioid painkiller fails to get FDA panel backing

The panel voted 8-7 against approving the treatment which is administered in hospitals and ambulatory surgery centers and aims to manage acute pain in patients for whom an intravenous opioid is necessary.

WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.